BASi (BASI) Names Dawn M. Joseph Director Of Business Development

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems, Inc. ("BASi") (NASDAQ:BASI) today announced the appointment of Dawn M. Joseph as Director of Business Development reporting to BASi Vice President of Business Development, Connie Dougherty. Ms. Dougherty said, "Dawn Joseph joins BASi with 11 years of experience in the pharmaceutical services market as a business development manager, with a track record of building sales and implementing winning initiatives for the clients.

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.